Dynemo Biosystems

Dynemo Biosystems - microarray gene expression analysis tools for pharmacogenomics, pharmacogenetics and prognostics relating to breast cancer, other cancers and other complex disease for use in clinical trials and personalized medicine

Home

Dynemo uses dynamic network modularity to predict clinical outcomes

News

Apr. 12, 2010:
MaRS Innovation to assist with business development and marketing

Jan. 28, 2009:
New technology discovered at Mount Sinai Hospital holds promise for improved breast cancer treatment

Events

Jun. 22, 2010:
Dx2010 Markers to Markets

Jun. 4 - 8, 2010:
2010 ASCO Annual Meeting, Chicago

Accurate, reproducible biomarker development platform for:

Change in protein network modularity relating to different clinical outcome